User profiles for Susan L. Slager

Susan Slager

Mayo Clinic
Verified email at mayo.edu
Cited by 34322

[PDF][PDF] Familial primary pulmonary hypertension (Gene PPH1) is caused by mutations in the bone morphogenetic protein receptor–II gene

Z Deng, JH Morse, SL Slager, N Cuervo… - The American Journal of …, 2000 - cell.com
Familial primary pulmonary hypertension is a rare autosomal dominant disorder that has
reduced penetrance and that has been mapped to a 3-cM region on chromosome 2q33 (locus …

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

…, B Knoechel, YW Asmann, SL Slager… - Proceedings of the …, 2012 - National Acad Sciences
To gain insight into the genomic basis of diffuse large B-cell lymphoma (DLBCL), we performed
massively parallel whole-exome sequencing of 55 primary tumor samples from patients …

[HTML][HTML] Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer

…, H Nevanlinna, D Yannoukakos, SL Slager… - Journal of clinical …, 2015 - ncbi.nlm.nih.gov
Purpose Recent advances in DNA sequencing have led to the development of breast
cancer susceptibility gene panels for germline genetic testing of patients. We assessed the …

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy

…, C Allmer, E Nicolas-Virelizier, SL Slager… - Journal of Clinical …, 2014 - ascopubs.org
Purpose Studies of diffuse large B-cell lymphoma (DLBCL) are typically evaluated by using
a time-to-event approach with relapse, re-treatment, and death commonly used as the events…

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

…, W Zheng, RG Ziegler, A Siddiq, SL Slager… - Nature …, 2011 - nature.com
Estrogen receptor (ER)-negative breast cancer shows a higher incidence in women of African
ancestry compared to women of European ancestry. In search of common risk alleles for …

[PDF][PDF] Mutations in CHEK2 associated with prostate cancer risk

…, SK McDonnell, C Qian, AF Marks, SL Slager… - The American Journal of …, 2003 - cell.com
The DNA-damage–signaling pathway has been implicated in all human cancers. However,
the genetic defects and the mechanisms of this pathway in prostate carcinogenesis remain …

Cigarette smoking and colorectal cancer risk by molecularly defined subtypes

…, LJ Harnack, JD Potter, SL Slager… - JNCI: Journal of the …, 2010 - academic.oup.com
Background Cigarette smoking is an established risk factor for colorectal cancer. Because
colorectal carcinogenesis is a heterogeneous process, we investigated whether cigarette …

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph non-Hodgkin lymphoma subtypes project

LM Morton, SL Slager, JR Cerhan… - Journal of the …, 2014 - academic.oup.com
Background Non-Hodgkin lymphoma (NHL) comprises biologically and clinically heterogeneous
subtypes. Previously, study size has limited the ability to compare and contrast the risk …

A genomewide association study of citalopram response in major depressive disorder

…, JS Yokoyama, GD Jenkins, MS Reinalda, SL Slager… - Biological …, 2010 - Elsevier
BACKGROUND: Antidepressant response is likely influenced by genetic constitution, but
the actual genes involved have yet to be determined. We have carried out a genomewide …

[HTML][HTML] Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Specialized …

…, WR Macon, SI Syrbu, SL Slager… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
Purpose This study sought to characterize transformation incidence and outcome for
patients with follicular lymphoma (FL) in a prospective observational series begun after …